Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 236-537-4 | CAS number: 13423-15-9
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
The oral Approximate Lethal Dose (ALD) is 5000 mg/kg, which is expected to equate to an LD50 between 3500-5000 mg/kg.
The inhalation Approximate Lethal Concentration (ALC) is >6700 PPM.
The dermal LD50 is >2000 mg/kg-bw based on read-across to the analog substance tetrahydrofuran.
Key value for chemical safety assessment
Additional information
Tetrahydro-3-methylfuran (3-methyl-THF) has been adequately characterized for acute toxicity via oral, dermal and inhalation routes. In key and supporting studies, the acute oral toxicity of 3-methyl-THF is low following oral gavage or inhalation. In rats, the oral Approximate Lethal Dose (ALD) is 5000 mg/kg (DuPont, 1969) and Approximate Lethal Concentration (ALC) is >6700 PPM (DuPont, 1985). Following inhalation, clinical signs included a diminished startle response during exposure and heavy breathing was observed after inhalation and oral gavage. Rats exposed to 6700 ppm were limp and prostrate. This low acute toxicity following oral administration or inhalation is supported by read-across to a closely related substance , Tetrahydrofuran (CAS# 109-99-9), in which, the oral LD50 was reported to 1650 mg/kg (Consumer Products Testing Company; 1978) and 2.3 mL/kg bw (1940 mg/kg bw [Kimura et al., 1971]) and the LC50 was reported to be >14.7 ppm (DuPont, 1996) . Clinical signs included a diminished response to alerting stimulus after 2 hours of exposure by inhalation. In a key study conducted according to currently accepted guidelines and with full GLP compliance, treatment of male and female Wistar rats semi-occlusively with neat tetrahydrofuran at 2000 mg/kg bw for 24 hours produced no mortality or clinical signs of toxicity (BASF, 2009). The acute dermal LD50 value was > 2000 mg/kg bwt from this study. In addition, tetrahydro-2 -methylfuran is reported to have a measured acute dermal LD50 of 4500 mg/kg bwt (Deichmann, W.B.; 1969). In the absence of reliable data to the contrary, and the low acute toxicity following other routes of exposure, it can be concluded 3-methyl-THF is not acutely toxic following dermal exposure and the overall acute toxicity of 3-methyl-THF is low.
Justification for classification or non-classification
Acute oral toxicity
Based on the results of acute oral toxicity testing (ALD, rat = 5000 mg/kg-bw; estimated LD50 between 3500 - 5000 mg/kg-bw), the substance is not classified as toxic by the oral route under the EU DSD classification criteria (EU Directive 67/548/EEC) or the EU CLP classification criteria (Regulation (EC) 1272/2008).
Acute inhalation toxicity
Based on the results of acute inhalation toxicity testing (ALC, rat >6700 ppm; >23.6 mg/l), the substance is not classified as toxic by inhalation under the EU DSD classification criteria (EU Directive 67/548/EEC) or the EU CLP classification criteria (Regulation (EC) 1272/2008). However, given that rats exposed to 3200 ppm and rats exposed to 6700 ppm had a diminished startle response during exposure, and rats exposed to 3200 ppm staggered when they were released from restrainers after exposure, and rats exposed to 6700 ppm were limp and prostrate; all characteristic of narcotic effects, the substance should be classified as R67, Vapours may cause drowsiness and dizziness, under the DSD regulation and as Specific Target Organ Toxicity - Single Exposure (STOT-SE), Category 3, under the CLP regulation.
Acute dermal toxicity
Based on the results of acute dermal toxicity testing for the read-across substance (LD50, rat > 2000 mg/kg-bw) the substance is not classified as harmful or toxic in contact with skin under the EU DSD classification criteria (EU Directive 67/548/EEC) or under the EU CLP classification criteria (Regulation (EC) 1272/2008).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.